The estimated Net Worth of Edward P Owens is at least $1.24 Million dollars as of 26 February 2021. Mr. Owens owns over 3,000 units of Ironwood Pharmaceuticals Inc stock worth over $952,450 and over the last 12 years he sold IRWD stock worth over $0. In addition, he makes $291,817 as Independent Director at Ironwood Pharmaceuticals Inc.
Sign up
Mr. Owens IRWD stock SEC Form 4 insiders trading
Edward has made over 3 trades of the Ironwood Pharmaceuticals Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he bought 3,000 units of IRWD stock worth $26,700 on 26 February 2021.
The largest trade he's ever made was buying 12,000 units of Ironwood Pharmaceuticals Inc stock on 24 February 2021 worth over $110,400. On average, Edward trades about 1,667 units every 122 days since 2013. As of 26 February 2021 he still owns at least 218,954 units of Ironwood Pharmaceuticals Inc stock.
You can see the complete history of Mr. Owens stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Edward Owens biography
Edward P. Owens is an Independent Director of the Company. Mr. Owens was previously partner, portfolio manager and global industry analyst with Wellington Management Company, LLP where he worked in investment management since 1974. He was the portfolio manager of the Vanguard Health Care Fund for 28 years from its inception in May 1984 until his retirement from Wellington in December 2012.Mr. Owens serves on the board of directors of Stealth BioTherapeutics Corp. He has a B.S. in physics from the University of Virginia and an M.B.A. from Harvard Business School. He brings to our board extensive experience in evaluating and investing in life sciences companies, providing valuable insight as we continue to strive towards our goal of maximizing long-term stockholder value.
What is the salary of Edward Owens?
As the Independent Director of Ironwood Pharmaceuticals Inc, the total compensation of Edward Owens at Ironwood Pharmaceuticals Inc is $291,817. There are 12 executives at Ironwood Pharmaceuticals Inc getting paid more, with Mark Mallon having the highest compensation of $10,068,800.
How old is Edward Owens?
Edward Owens is 73, he's been the Independent Director of Ironwood Pharmaceuticals Inc since 2013. There are no older and 19 younger executives at Ironwood Pharmaceuticals Inc.
What's Edward Owens's mailing address?
Edward's mailing address filed with the SEC is C/O IRONWOOD PHARMACEUTICALS, INC., 100 SUMMER STREET, SUITE 2300, BOSTON, MA, 02110.
Insiders trading at Ironwood Pharmaceuticals Inc
Over the last 15 years, insiders at Ironwood Pharmaceuticals Inc have traded over $83,928,361 worth of Ironwood Pharmaceuticals Inc stock and bought 2,478,676 units worth $24,100,589 . The most active insiders traders include Llc Fmr, Bryan E Roberts, and Alexander J Denner. On average, Ironwood Pharmaceuticals Inc executives and independent directors trade stock every 19 days with the average trade being worth of $239,611. The most recent stock trade was executed by Minardo John on 12 August 2024, trading 9,910 units of IRWD stock currently worth $42,316.
What does Ironwood Pharmaceuticals Inc do?
ironwood pharmaceuticals (nasdaq: irwd) is focused on creating medicines that make a difference for patients, building value to earn the continued support of our fellow shareholders, and empowering our passionate team to keep doing these two things again and again as we continue to build a leading gastrointestinal therapeutics company. we discovered, developed and are commercializing a medicine for the treatment of adults suffering from irritable bowel syndrome with constipation (ibs-c) or chronic idiopathic constipation (cic). we are also developing a rich pipeline of programs seeking to address patient needs across the upper and lower gastrointestinal tract. our pipeline priorities include exploring further opportunities for our lead medicine, as well as leveraging our therapeutic expertise in gastrointestinal disorders and our pharmacologic expertise in guanylate cyclases to advance multiple investigational medicines. ironwood was founded in 1998 out of the whitehead institute for b
What does Ironwood Pharmaceuticals Inc's logo look like?
Complete history of Mr. Owens stock trades at Ironwood Pharmaceuticals Inc
Ironwood Pharmaceuticals Inc executives and stock owners
Ironwood Pharmaceuticals Inc executives and other stock owners filed with the SEC include:
-
Mark Mallon,
Chief Executive Officer, Director -
Thomas McCourt,
President -
Mark Currie,
Director -
Gina Consylman,
Chief Financial Officer, Senior Vice President -
Thomas A. McCourt,
CEO & Director -
Jason Rickard,
COO & Sr. VP of Operations -
Dr. Michael Shetzline M.D., Ph.D.,
Chief Medical Officer, Sr. VP and Head of R&D -
Catherine Moukheibir,
Independent Director -
Jon Duane,
Independent Director -
Marla Kessler,
Independent Director -
Julie McHugh,
Independent Chairman of the Board -
Andrew Dreyfus,
Independent Director -
Edward Owens,
Independent Director -
Lawrence Olanoff,
Independent Director -
Julie H. McHugh,
Exec. Chairman -
Alexander Denner,
Director -
Meredith Kaya,
Vice President - Investor Relations and Corporate Communications -
Michael Shetzline,
Chief Medical Officer, Senior Vice President and Head of Drug Development -
Conor Kilroy,
Senior Vice President, General Counsel -
Jason Rickard,
Chief Operating Officer, Senior Vice President -
John Minardo,
Sr. VP & Chief Legal Officer -
Marcel Moulaison,
VP of Technical Operations -
Ronald Silver,
Corp. Controller & Principal Accounting Officer -
Sravan Kumar Emany,
Sr. VP & CFO -
G. Todd Milne,
Co-Founder and VP of sGC R&D -
Brian M. Cali,
Co-Founder and Sr. VP of R&D Strategy & External Innovation -
Terrance Mcguire,
Director -
Douglas E Williams,
Director -
Amy W Schulman,
Director -
Marsha Fanucci,
Director -
Christopher T Phd Walsh,
Director -
Peter M Hecht,
Chief Executive Officer -
Thomas Graney,
Chief Financial Officer -
William Huyett,
Chief Operating Officer -
Halley E Gilbert,
Chief Admin Officer & SVP -
Bryan E Roberts,
Director -
Associatesvenrock Associate...,
-
Management Llc Vr,
10% owner -
Llc Fmr,
10% owner -
Llcfil Ltd Fmr,
-
Co Investment Holdings, Llc...,
-
Capital Investments L.P.Rid...,
-
Joseph C Jr Cook,
Director -
George H Conrades,
Director -
David Evans Shaw,
Director -
David A Ebersman,
Director -
Michael J Higgins,
Chief Operating Officer -
Kelly Mac Donald,
Chief Accounting Officer -
Jay Shepard,
-
Sravan Kumar Emany,
SVP, Chief Financial Officer -
Alexander J Sarissa Capital...,
-
Andrew Davis,
SVP, Chief Business Officer -
Ronald Silver,
Principal Accounting Officer -
Minardo John,
Chief Legal Officer